Trial intelligence / Profile preview

Rizatriptan Clinical vs Formulary Limit in Migraine

NCT00397254Phase 4Completed

Sponsor
Clinvest Research
Start
Dec 2006
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rizatriptan in migraine, sponsored by Clinvest Research. Started Dec 2006; status: completed.

02

Drugs

rizatriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00397254.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00397254.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call